The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis

Peter, E. L. and Nagendrappa, P. B. and Kaligirwa, A. and Ogwang, P. E. and Sesaazi, C. D.

Phytother Res (2021) 35: 637–656

DOI: 10.1002/ptr.6853

Abstract

Type 2 diabetes mellitus is a chronic hyperglycemic condition due to progressively impaired glucose regulation. Momordica charantia L. could potentially improve hyperglycemia because its fruit extracts can alleviate insulin resistance, beta-cell dysfunction, and increase serum insulin level. We evaluated the effect of M. charantia L. in comparison with a vehicle on glycemic control in animal models of type 2 diabetes mellitus. MEDLINE, Web of Science, Scopus, and CINAHL databases were searched without language restriction through April 2019. About 66 studies involving 1861 animals that examined the effect of M. charantia L. on type 2 diabetes mellitus were included. Fruits and seed extracts reduced fasting plasma glucose (FPG) and glycosylated hemoglobin A1c in comparison to vehicle control: (42 studies, 815 animals; SMD, -6.86 [95% CI; -7.95, -5.77], 3 studies, 59 animals; SMD; -7.76 [95% CI; -12.50, -3.01]) respectively. Also, the extracts have hepato-renal protective effects at varying doses and duration of administration. Despite the observed significant glycemic control effect, poor methodological quality calls for future researches to focus on standardizing extract based on chemical markers and adopt measures to improve the quality of preclinical studies such as sample size calculation, randomization, and blinding.

Citation

Peter, E. L., Nagendrappa, P. B., Kaligirwa, A., Ogwang, P. E., & Sesaazi, C. D. (2021). The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis. Phytother Res, 35(2), 637–656. https://doi.org/10.1002/ptr.6853 Animals, meta-analysis, safety, efficacy, preclinical, Phytotherapy, Diabetes Mellitus, Type 2/*drug therapy, Hypoglycemic Agents/*therapeutic use, type 2 diabetes mellitus, Diabetes Mellitus, Experimental/*drug therapy, Plant Extracts/*therapeutic use, *Momordica charantia, bitter gourd

Keywords

• Animals
• meta-analysis
• safety
• efficacy
• preclinical
• Phytotherapy
• Diabetes Mellitus
• Type 2/*drug therapy
• Hypoglycemic Agents/*therapeutic use
• type 2 diabetes mellitus
• Diabetes Mellitus
• Experimental/*drug therapy
• Plant Extracts/*therapeutic use
• *Momordica charantia
• bitter gourd